Chemfab Alkalis: In the Board meeting held today i.e., 28th October, 2026, the Board has approved Un-Audited Standalone and…
Chemfab Alkalis (CHEMFAB) filed a disclosure titled "In the Board meeting held today i.e., 28th October, 2026, the Board has approved Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th…". The company is valued…
What happened
Chemfab Alkalis (CHEMFAB) filed a disclosure with the exchanges on 28 October 2026 at 07:19 PM titled "In the Board meeting held today i.e., 28th October, 2026, the Board has approved Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th…".
Company snapshot
Chemfab Alkalis is a micro-cap company, with a market value of about ₹445 crore.
The stock last traded at ₹309.4, against a 52-week range of ₹288.3–₹625.5 (50.5% below the high).
Before this filing the shares had moved −12.7% over the month and −17.1% over three months. Average daily turnover over the last 20 sessions was about ₹0.1 crore.
Promoters held 72.13% at the end of Q1 FY27. Foreign institutions owned 0.04% and domestic institutions 0.07%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 92 | 2.5 | 1.77 |
| Q2 FY26 | 77 | -2 | 1.4 |
| Q3 FY26 | 68 | -4.4 | -3.09 |
| Q4 FY26 | 75 | 0.5 | 0.34 |
| Q1 FY27 | 73 | 5.7 | 3.99 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
Market-wide, 9,836 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 28 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.